PREVENTION OF AFFECTIONS ASSOCIATED WITH PORCINE CIRCOVIRUS-2
Porcine circovirus-2 (PCV-2) is a recently identified agent wherein the potential spectrum of PCV-2-associated disease has been expanded by evidence of vertical and sexual transmission and associated reproductive failure in swine populations. PCV-2 was isolated from a litter of aborted piglets from...
Gespeichert in:
Hauptverfasser: | , , , , , , , , , , , |
---|---|
Format: | Patent |
Sprache: | eng ; fre ; ger |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | |
container_start_page | |
container_title | |
container_volume | |
creator | MCNEILLY, FRANCIS HAINES, DEBORAH HASSARD, LORI CLARK, EDWARD HARDING, JOHN ALLAN, GORDON, MOORE ELLIS, JOHN ALBERT KRAKOWKA, GEORGE, STEVE AUDONNET, JEANRISTOPHE, FRANCIS CHARREYRE, CATHERINE, ELISABETH CHAPPUIS, GILLES, EMILE MEEHAN, BRIAN |
description | Porcine circovirus-2 (PCV-2) is a recently identified agent wherein the potential spectrum of PCV-2-associated disease has been expanded by evidence of vertical and sexual transmission and associated reproductive failure in swine populations. PCV-2 was isolated from a litter of aborted piglets from a farm experiencing late term abortions and stillbirths. Severe, diffuse myocarditis was present in one piglet associated with extensive immunohistochemical staining for PCV-2 antigen. Variable amounts of PCV-2 antigen were also present in liver, lung and kidney of multiple fetuses. Inoculation of female pigs with a composition including an immunogen from PCV-2 or an epitope of interest from such an immunogen or with a vector expressing such an immunogen or epitope of interest prior to breeding, such as within the first five weeks of life, or prior to the perinatal period, or repeatedly over a lifetime, or during pregnancy, such as between the 6th and 8th and/or the 10th and 13th weeks of gestation, can prevent myocarditis, abortion and intrauterine infection associated with porcine circovirus-2. In addition, innoculation of male and/or female pigs with the aforementioned compositions can be carried out to prevent transmission of PCV-2 from male to female (or vice versa) during mating. Thus, the invention involves methods and compositions for preventing myocarditis, abortion and intrauterine infection associated with porcine circovirus-2. |
format | Patent |
fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_EP1246920B1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>EP1246920B1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_EP1246920B13</originalsourceid><addsrcrecordid>eNrjZLANCHINc_UL8fT3U_B3U3B0c3N1BnGCFRyDg_2dPR1DXF0Uwj1DPBQC_IOcPf1cFZw9g5z9wzyDQoN1jXgYWNMSc4pTeaE0N4OCm2uIs4duakF-fGpxQWJyal5qSbxrgKGRiZmlkYGToTERSgDzCSmT</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>PREVENTION OF AFFECTIONS ASSOCIATED WITH PORCINE CIRCOVIRUS-2</title><source>esp@cenet</source><creator>MCNEILLY, FRANCIS ; HAINES, DEBORAH ; HASSARD, LORI ; CLARK, EDWARD ; HARDING, JOHN ; ALLAN, GORDON, MOORE ; ELLIS, JOHN ALBERT ; KRAKOWKA, GEORGE, STEVE ; AUDONNET, JEANRISTOPHE, FRANCIS ; CHARREYRE, CATHERINE, ELISABETH ; CHAPPUIS, GILLES, EMILE ; MEEHAN, BRIAN</creator><creatorcontrib>MCNEILLY, FRANCIS ; HAINES, DEBORAH ; HASSARD, LORI ; CLARK, EDWARD ; HARDING, JOHN ; ALLAN, GORDON, MOORE ; ELLIS, JOHN ALBERT ; KRAKOWKA, GEORGE, STEVE ; AUDONNET, JEANRISTOPHE, FRANCIS ; CHARREYRE, CATHERINE, ELISABETH ; CHAPPUIS, GILLES, EMILE ; MEEHAN, BRIAN</creatorcontrib><description>Porcine circovirus-2 (PCV-2) is a recently identified agent wherein the potential spectrum of PCV-2-associated disease has been expanded by evidence of vertical and sexual transmission and associated reproductive failure in swine populations. PCV-2 was isolated from a litter of aborted piglets from a farm experiencing late term abortions and stillbirths. Severe, diffuse myocarditis was present in one piglet associated with extensive immunohistochemical staining for PCV-2 antigen. Variable amounts of PCV-2 antigen were also present in liver, lung and kidney of multiple fetuses. Inoculation of female pigs with a composition including an immunogen from PCV-2 or an epitope of interest from such an immunogen or with a vector expressing such an immunogen or epitope of interest prior to breeding, such as within the first five weeks of life, or prior to the perinatal period, or repeatedly over a lifetime, or during pregnancy, such as between the 6th and 8th and/or the 10th and 13th weeks of gestation, can prevent myocarditis, abortion and intrauterine infection associated with porcine circovirus-2. In addition, innoculation of male and/or female pigs with the aforementioned compositions can be carried out to prevent transmission of PCV-2 from male to female (or vice versa) during mating. Thus, the invention involves methods and compositions for preventing myocarditis, abortion and intrauterine infection associated with porcine circovirus-2.</description><language>eng ; fre ; ger</language><subject>BEER ; BIOCHEMISTRY ; CHEMISTRY ; COMPOSITIONS OR TEST PAPERS THEREFOR ; COMPOSITIONS THEREOF ; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES ; CULTURE MEDIA ; ENZYMOLOGY ; HUMAN NECESSITIES ; HYGIENE ; MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; MICROBIOLOGY ; MICROORGANISMS OR ENZYMES ; MUTATION OR GENETIC ENGINEERING ; ORGANIC CHEMISTRY ; PEPTIDES ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; PROCESSES OF PREPARING SUCH COMPOSITIONS ; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS ; SPIRITS ; VINEGAR ; WINE</subject><creationdate>2011</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20111005&DB=EPODOC&CC=EP&NR=1246920B1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20111005&DB=EPODOC&CC=EP&NR=1246920B1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>MCNEILLY, FRANCIS</creatorcontrib><creatorcontrib>HAINES, DEBORAH</creatorcontrib><creatorcontrib>HASSARD, LORI</creatorcontrib><creatorcontrib>CLARK, EDWARD</creatorcontrib><creatorcontrib>HARDING, JOHN</creatorcontrib><creatorcontrib>ALLAN, GORDON, MOORE</creatorcontrib><creatorcontrib>ELLIS, JOHN ALBERT</creatorcontrib><creatorcontrib>KRAKOWKA, GEORGE, STEVE</creatorcontrib><creatorcontrib>AUDONNET, JEANRISTOPHE, FRANCIS</creatorcontrib><creatorcontrib>CHARREYRE, CATHERINE, ELISABETH</creatorcontrib><creatorcontrib>CHAPPUIS, GILLES, EMILE</creatorcontrib><creatorcontrib>MEEHAN, BRIAN</creatorcontrib><title>PREVENTION OF AFFECTIONS ASSOCIATED WITH PORCINE CIRCOVIRUS-2</title><description>Porcine circovirus-2 (PCV-2) is a recently identified agent wherein the potential spectrum of PCV-2-associated disease has been expanded by evidence of vertical and sexual transmission and associated reproductive failure in swine populations. PCV-2 was isolated from a litter of aborted piglets from a farm experiencing late term abortions and stillbirths. Severe, diffuse myocarditis was present in one piglet associated with extensive immunohistochemical staining for PCV-2 antigen. Variable amounts of PCV-2 antigen were also present in liver, lung and kidney of multiple fetuses. Inoculation of female pigs with a composition including an immunogen from PCV-2 or an epitope of interest from such an immunogen or with a vector expressing such an immunogen or epitope of interest prior to breeding, such as within the first five weeks of life, or prior to the perinatal period, or repeatedly over a lifetime, or during pregnancy, such as between the 6th and 8th and/or the 10th and 13th weeks of gestation, can prevent myocarditis, abortion and intrauterine infection associated with porcine circovirus-2. In addition, innoculation of male and/or female pigs with the aforementioned compositions can be carried out to prevent transmission of PCV-2 from male to female (or vice versa) during mating. Thus, the invention involves methods and compositions for preventing myocarditis, abortion and intrauterine infection associated with porcine circovirus-2.</description><subject>BEER</subject><subject>BIOCHEMISTRY</subject><subject>CHEMISTRY</subject><subject>COMPOSITIONS OR TEST PAPERS THEREFOR</subject><subject>COMPOSITIONS THEREOF</subject><subject>CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES</subject><subject>CULTURE MEDIA</subject><subject>ENZYMOLOGY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>MICROBIOLOGY</subject><subject>MICROORGANISMS OR ENZYMES</subject><subject>MUTATION OR GENETIC ENGINEERING</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>PROCESSES OF PREPARING SUCH COMPOSITIONS</subject><subject>PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><subject>SPIRITS</subject><subject>VINEGAR</subject><subject>WINE</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2011</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZLANCHINc_UL8fT3U_B3U3B0c3N1BnGCFRyDg_2dPR1DXF0Uwj1DPBQC_IOcPf1cFZw9g5z9wzyDQoN1jXgYWNMSc4pTeaE0N4OCm2uIs4duakF-fGpxQWJyal5qSbxrgKGRiZmlkYGToTERSgDzCSmT</recordid><startdate>20111005</startdate><enddate>20111005</enddate><creator>MCNEILLY, FRANCIS</creator><creator>HAINES, DEBORAH</creator><creator>HASSARD, LORI</creator><creator>CLARK, EDWARD</creator><creator>HARDING, JOHN</creator><creator>ALLAN, GORDON, MOORE</creator><creator>ELLIS, JOHN ALBERT</creator><creator>KRAKOWKA, GEORGE, STEVE</creator><creator>AUDONNET, JEANRISTOPHE, FRANCIS</creator><creator>CHARREYRE, CATHERINE, ELISABETH</creator><creator>CHAPPUIS, GILLES, EMILE</creator><creator>MEEHAN, BRIAN</creator><scope>EVB</scope></search><sort><creationdate>20111005</creationdate><title>PREVENTION OF AFFECTIONS ASSOCIATED WITH PORCINE CIRCOVIRUS-2</title><author>MCNEILLY, FRANCIS ; HAINES, DEBORAH ; HASSARD, LORI ; CLARK, EDWARD ; HARDING, JOHN ; ALLAN, GORDON, MOORE ; ELLIS, JOHN ALBERT ; KRAKOWKA, GEORGE, STEVE ; AUDONNET, JEANRISTOPHE, FRANCIS ; CHARREYRE, CATHERINE, ELISABETH ; CHAPPUIS, GILLES, EMILE ; MEEHAN, BRIAN</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_EP1246920B13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre ; ger</language><creationdate>2011</creationdate><topic>BEER</topic><topic>BIOCHEMISTRY</topic><topic>CHEMISTRY</topic><topic>COMPOSITIONS OR TEST PAPERS THEREFOR</topic><topic>COMPOSITIONS THEREOF</topic><topic>CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES</topic><topic>CULTURE MEDIA</topic><topic>ENZYMOLOGY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>MICROBIOLOGY</topic><topic>MICROORGANISMS OR ENZYMES</topic><topic>MUTATION OR GENETIC ENGINEERING</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>PROCESSES OF PREPARING SUCH COMPOSITIONS</topic><topic>PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><topic>SPIRITS</topic><topic>VINEGAR</topic><topic>WINE</topic><toplevel>online_resources</toplevel><creatorcontrib>MCNEILLY, FRANCIS</creatorcontrib><creatorcontrib>HAINES, DEBORAH</creatorcontrib><creatorcontrib>HASSARD, LORI</creatorcontrib><creatorcontrib>CLARK, EDWARD</creatorcontrib><creatorcontrib>HARDING, JOHN</creatorcontrib><creatorcontrib>ALLAN, GORDON, MOORE</creatorcontrib><creatorcontrib>ELLIS, JOHN ALBERT</creatorcontrib><creatorcontrib>KRAKOWKA, GEORGE, STEVE</creatorcontrib><creatorcontrib>AUDONNET, JEANRISTOPHE, FRANCIS</creatorcontrib><creatorcontrib>CHARREYRE, CATHERINE, ELISABETH</creatorcontrib><creatorcontrib>CHAPPUIS, GILLES, EMILE</creatorcontrib><creatorcontrib>MEEHAN, BRIAN</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>MCNEILLY, FRANCIS</au><au>HAINES, DEBORAH</au><au>HASSARD, LORI</au><au>CLARK, EDWARD</au><au>HARDING, JOHN</au><au>ALLAN, GORDON, MOORE</au><au>ELLIS, JOHN ALBERT</au><au>KRAKOWKA, GEORGE, STEVE</au><au>AUDONNET, JEANRISTOPHE, FRANCIS</au><au>CHARREYRE, CATHERINE, ELISABETH</au><au>CHAPPUIS, GILLES, EMILE</au><au>MEEHAN, BRIAN</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>PREVENTION OF AFFECTIONS ASSOCIATED WITH PORCINE CIRCOVIRUS-2</title><date>2011-10-05</date><risdate>2011</risdate><abstract>Porcine circovirus-2 (PCV-2) is a recently identified agent wherein the potential spectrum of PCV-2-associated disease has been expanded by evidence of vertical and sexual transmission and associated reproductive failure in swine populations. PCV-2 was isolated from a litter of aborted piglets from a farm experiencing late term abortions and stillbirths. Severe, diffuse myocarditis was present in one piglet associated with extensive immunohistochemical staining for PCV-2 antigen. Variable amounts of PCV-2 antigen were also present in liver, lung and kidney of multiple fetuses. Inoculation of female pigs with a composition including an immunogen from PCV-2 or an epitope of interest from such an immunogen or with a vector expressing such an immunogen or epitope of interest prior to breeding, such as within the first five weeks of life, or prior to the perinatal period, or repeatedly over a lifetime, or during pregnancy, such as between the 6th and 8th and/or the 10th and 13th weeks of gestation, can prevent myocarditis, abortion and intrauterine infection associated with porcine circovirus-2. In addition, innoculation of male and/or female pigs with the aforementioned compositions can be carried out to prevent transmission of PCV-2 from male to female (or vice versa) during mating. Thus, the invention involves methods and compositions for preventing myocarditis, abortion and intrauterine infection associated with porcine circovirus-2.</abstract><oa>free_for_read</oa></addata></record> |
fulltext | fulltext_linktorsrc |
identifier | |
ispartof | |
issn | |
language | eng ; fre ; ger |
recordid | cdi_epo_espacenet_EP1246920B1 |
source | esp@cenet |
subjects | BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS OR TEST PAPERS THEREFOR COMPOSITIONS THEREOF CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES CULTURE MEDIA ENZYMOLOGY HUMAN NECESSITIES HYGIENE MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS MEDICAL OR VETERINARY SCIENCE METALLURGY MICROBIOLOGY MICROORGANISMS OR ENZYMES MUTATION OR GENETIC ENGINEERING ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES PROCESSES OF PREPARING SUCH COMPOSITIONS PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS SPIRITS VINEGAR WINE |
title | PREVENTION OF AFFECTIONS ASSOCIATED WITH PORCINE CIRCOVIRUS-2 |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-21T11%3A09%3A47IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=MCNEILLY,%20FRANCIS&rft.date=2011-10-05&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EEP1246920B1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |